Literature DB >> 18394581

Bayesian meta-analysis of genetic association studies with different sets of markers.

Claudio Verzilli1, Tina Shah, Juan P Casas, Juliet Chapman, Manjinder Sandhu, Sally L Debenham, Matthijs S Boekholdt, Kay Tee Khaw, Nicholas J Wareham, Richard Judson, Emelia J Benjamin, Sekar Kathiresan, Martin G Larson, Jian Rong, Reecha Sofat, Steve E Humphries, Liam Smeeth, Gianpiero Cavalleri, John C Whittaker, Aroon D Hingorani.   

Abstract

Robust assessment of genetic effects on quantitative traits or complex-disease risk requires synthesis of evidence from multiple studies. Frequently, studies have genotyped partially overlapping sets of SNPs within a gene or region of interest, hampering attempts to combine all the available data. By using the example of C-reactive protein (CRP) as a quantitative trait, we show how linkage disequilibrium in and around its gene facilitates use of Bayesian hierarchical models to integrate informative data from all available genetic association studies of this trait, irrespective of the SNP typed. A variable selection scheme, followed by contextualization of SNPs exhibiting independent associations within the haplotype structure of the gene, enhanced our ability to infer likely causal variants in this region with population-scale data. This strategy, based on data from a literature based systematic review and substantial new genotyping, facilitated the most comprehensive evaluation to date of the role of variants governing CRP levels, providing important information on the minimal subset of SNPs necessary for comprehensive evaluation of the likely causal relevance of elevated CRP levels for coronary-heart-disease risk by Mendelian randomization. The same method could be applied to evidence synthesis of other quantitative traits, whenever the typed SNPs vary among studies, and to assist fine mapping of causal variants.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18394581      PMCID: PMC2665011          DOI: 10.1016/j.ajhg.2008.01.016

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  29 in total

Review 1.  Meta-analysis: formulating, evaluating, combining, and reporting.

Authors:  S L Normand
Journal:  Stat Med       Date:  1999-02-15       Impact factor: 2.373

2.  Assessing the impact of biobanks.

Authors:  Anne Cambon-Thomsen
Journal:  Nat Genet       Date:  2003-05       Impact factor: 38.330

3.  An evaluation of HapMap sample size and tagging SNP performance in large-scale empirical and simulated data sets.

Authors:  Eleftheria Zeggini; William Rayner; Andrew P Morris; Andrew T Hattersley; Mark Walker; Graham A Hitman; Panos Deloukas; Lon R Cardon; Mark I McCarthy
Journal:  Nat Genet       Date:  2005-10-30       Impact factor: 38.330

4.  Nature's randomised trials.

Authors:  Aroon Hingorani; Steve Humphries
Journal:  Lancet       Date:  2005-12-03       Impact factor: 79.321

5.  Open-access database of candidate associations from a genome-wide SNP scan of the Framingham Heart Study.

Authors:  Alan Herbert; Marc E Lenburg; David Ulrich; Norman P Gerry; Karen Schlauch; Michael F Christman
Journal:  Nat Genet       Date:  2007-02       Impact factor: 38.330

6.  C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study.

Authors:  Isabella Kardys; Moniek P M de Maat; André G Uitterlinden; Albert Hofman; Jacqueline C M Witteman
Journal:  Eur Heart J       Date:  2006-05-03       Impact factor: 29.983

7.  Feasibility of heart-rate monitoring to estimate total level and pattern of energy expenditure in a population-based epidemiological study: the Ely Young Cohort Feasibility Study 1994-5.

Authors:  N J Wareham; S J Hennings; A M Prentice; N E Day
Journal:  Br J Nutr       Date:  1997-12       Impact factor: 3.718

Review 8.  C-reactive protein and cardiovascular disease: new insights from an old molecule.

Authors:  G M Hirschfield; M B Pepys
Journal:  QJM       Date:  2003-11

9.  Genetic effects on baseline values of C-reactive protein and serum amyloid a protein: a comparison of monozygotic and dizygotic twins.

Authors:  Alex J MacGregor; J Ruth Gallimore; Tim D Spector; Mark B Pepys
Journal:  Clin Chem       Date:  2003-11-18       Impact factor: 8.327

10.  The emergence of networks in human genome epidemiology: challenges and opportunities.

Authors:  Daniela Seminara; Muin J Khoury; Thomas R O'Brien; Teri Manolio; Marta L Gwinn; Julian Little; Julian P T Higgins; Jonine L Bernstein; Paolo Boffetta; Melissa Bondy; Molly S Bray; Paul E Brenchley; Patricia A Buffler; Juan Pablo Casas; Anand P Chokkalingam; John Danesh; George Davey Smith; Siobhan Dolan; Ross Duncan; Nelleke A Gruis; Mia Hashibe; David Hunter; Marjo-Riitta Jarvelin; Beatrice Malmer; Demetrius M Maraganore; Julia A Newton-Bishop; Elio Riboli; Georgia Salanti; Emanuela Taioli; Nic Timpson; André G Uitterlinden; Paolo Vineis; Nick Wareham; Deborah M Winn; Ron Zimmern; John P A Ioannidis
Journal:  Epidemiology       Date:  2007-01       Impact factor: 4.822

View more
  32 in total

1.  Bayesian genome- and epigenome-wide association studies with gene level dependence.

Authors:  Eric F Lock; David B Dunson
Journal:  Biometrics       Date:  2017-01-12       Impact factor: 2.571

Review 2.  Prioritizing GWAS results: A review of statistical methods and recommendations for their application.

Authors:  Rita M Cantor; Kenneth Lange; Janet S Sinsheimer
Journal:  Am J Hum Genet       Date:  2010-01       Impact factor: 11.025

Review 3.  Bayesian statistical methods for genetic association studies.

Authors:  Matthew Stephens; David J Balding
Journal:  Nat Rev Genet       Date:  2009-10       Impact factor: 53.242

4.  C-reactive protein (CRP) polymorphisms and haplotypes are associated with SLE susceptibility and activity but not with serum CRP levels in Mexican population.

Authors:  Yemil Atisha-Fregoso; Guadalupe Lima; Eduardo Carrillo-Maravilla; Rosalinda Posadas-Sánchez; Nonanzit Pérez-Hernández; Miguel Baños-Peláez; Alejandra Iturralde-Chávez; Nora Hernández-Díaz; Juan Jakez-Ocampo; José Manuel Rodríguez-Pérez; Gilberto Vargas-Alarcón; Luis Llorente; Juanita Romero-Díaz
Journal:  Clin Rheumatol       Date:  2018-03-20       Impact factor: 2.980

5.  Unraveling the directional link between adiposity and inflammation: a bidirectional Mendelian randomization approach.

Authors:  Paul Welsh; Eliana Polisecki; Michele Robertson; Sabine Jahn; Brendan M Buckley; Anton J M de Craen; Ian Ford; J Wouter Jukema; Peter W Macfarlane; Chris J Packard; David J Stott; Rudi G J Westendorp; James Shepherd; Aroon D Hingorani; George Davey Smith; Ernst Schaefer; Naveed Sattar
Journal:  J Clin Endocrinol Metab       Date:  2009-11-11       Impact factor: 5.958

6.  Collaborative pooled analysis of data on C-reactive protein gene variants and coronary disease: judging causality by Mendelian randomisation.

Authors: 
Journal:  Eur J Epidemiol       Date:  2008-04-19       Impact factor: 8.082

7.  BAYESIAN METHODS FOR GENETIC ASSOCIATION ANALYSIS WITH HETEROGENEOUS SUBGROUPS: FROM META-ANALYSES TO GENE-ENVIRONMENT INTERACTIONS.

Authors:  Xiaoquan Wen; Matthew Stephens
Journal:  Ann Appl Stat       Date:  2014       Impact factor: 2.083

8.  Fine-mapping the genetic basis of CRP regulation in African Americans: a Bayesian approach.

Authors:  Benjamin Rhodes; David L Morris; Lakshman Subrahmanyan; Cristin Aubin; Carlos F Mendes de Leon; Jeremiah F Kelly; Dennis A Evans; John C Whittaker; Jorge R Oksenberg; Philip L De Jager; Tim J Vyse
Journal:  Hum Genet       Date:  2008-05-24       Impact factor: 4.132

9.  Systematic reviews of genetic association studies. Human Genome Epidemiology Network.

Authors:  Gurdeep S Sagoo; Julian Little; Julian P T Higgins
Journal:  PLoS Med       Date:  2009-03-03       Impact factor: 11.069

10.  A genetic association study of serum acute-phase C-reactive protein levels in rheumatoid arthritis: implications for clinical interpretation.

Authors:  Benjamin Rhodes; Marilyn E Merriman; Andrew Harrison; Michael J Nissen; Malcolm Smith; Lisa Stamp; Sophia Steer; Tony R Merriman; Timothy J Vyse
Journal:  PLoS Med       Date:  2010-09-21       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.